November 7, 2017
On November 7, 2017, Interaxon Inc., a brain health technology company headquartered in Toronto, announced the completion of a US$11.6 million Series B-1 funding round led by Trend Forward Capital, Export Development Canada and OMERS Ventures.
Interaxon will use the funding to accelerate the company’s expansion into the health and wellness space and support the release of new applications and services for Muse, Interaxon’s flagship product and core technology within its brain health platform.
Miller Thomson advised Interaxon with respect to this funding with a team led by Robert Stewart (corporate – venture capital) and that included Corey Yermus (corporate – venture capital), Ron Choudhury (tax) and Karen Durell (IP/IT).
